🔗 Share this article

An senior health official was recused of involvement in a major research project into hormone suppressants subsequent to allegations regarding bias emerged.

Reported Intervention Resulted in Trial Pause

Per news coverage, Prof Jacob George, the head scientific advisor for the medicines regulator, raised concerns which led to the halting of the national research initiative during early 2024.

The regulator stated recently that the professor would recuse him of involvement in the study once gender-critical social media posts made last year emerged.

Nature Regarding the Online Comments

In one comment, George described writer the Harry Potter author as an asset in modern society.” Elsewhere, the professor stated that the rejection of basic biological fact was troubling” regarding questions about a Olympic boxer’s gender.

The regulator stated that while George’s posts occurred prior to his appointment, the official had been recused of involvement with the study as an precaution.

Particulars of the Halted Pathways Study

The Pathways trial, that was intended to assess the effect of puberty blockers on adolescents uncertain about their own gender identity, was due to commence enrolling participants during January.

Yet, it was paused during the following month when the agency raised concerns regarding the welfare of young participants taking part.

• The youngest subjects were expected to start at 10 to 11 among assigned female at birth and eleven to twelve for assigned male at birth.
• Its study leadership noted previously that the strict screening process suggested participants would probably be older.
• But, the agency has now stated the minimum age limit should be fourteen because of an uncertain potential” for lasting physical side effects.”

The research aimed to recruit an estimated 226 youths during the coming three years.

Background and the Independent Report

The study was initiated after a suggestion from the Cass review into youth gender identity services, that concluded how the quality of the evidence purporting to demonstrate the benefits from this type of treatment for adolescents with gender incongruence were low-quality.”

Doctor Hilary Cass, who led that review, had earlier said the report exposed a very weak scientific foundation” supporting the benefits of puberty blockers.

Dr. Cass added, “given that there are doctors, children and parents who believe strongly of the beneficial effects, a trial remained the sole method forward to understand the situation.”

Expert Criticism Regarding the Action

Dr Max Davie, a consultant paediatrician, said there existed no compelling evidence-based justification to suspend the research.

“The tweets by Professor George provide an obvious insight into his own opinions on this issue,” he said. “He is free to hold any opinions about this subject he may, but what is improper is allow these opinions to affect the execution of his regulatory responsibilities.”

He continued: “It must be understood, there exists no persuasive scientific reason to pause this study. While Prof George’s personal convictions are not the only potential reason of the regulator’s sudden change of position, they are the single factor where we possess proof.”

Agency Response and Future Actions

A MHRA representative said: “With all medical studies, the MHRA’s foremost duty is the protection as well as welfare of the volunteers. As part of that commitment, complex studies are kept constantly under scrutiny and the MHRA keeps an ongoing scientific dialogue alongside trial sponsors.”

“The MHRA has world-class scientific, medical and oversight professionals who work as a collaborative team to provide scientifically sound decisions regarding medical research. This team shall persist to work alongside the organizers to work through the future path productively.”

“After the identification regarding online activity posted before his appointment, Prof Jacob George is recused of any additional involvement on the Pathways study as an abundance of caution.”